Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smart Measurement of Circulating Tumor DNA: a Tumor-agnostic Computational Tool to Improve Colorectal Cancer Care

NCT06989814 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06989814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06989814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smart Measurement of Circulating Tumor DNA: a Tumor-agnostic Computational Tool to Improve Colorectal Cancer Care
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 16, 2025
Completion date
February 1, 2027
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, colorectal neoplasms malignant, colorectal neoplasms, hereditary nonpolyposis, hereditary nonpolyposis colon cancer